Variables Controls (n = 62) Total PCOS (n = 40) NIR-PCOS (n = 22) IR-PCOS (n = 18)
TSH (μIU/ml) 2.29 ± 0.76b* 2.7 ± 1.23 2.3 ± 1.11b* 3.15 ± 1.34
FT3 (Pg/ml) 2.8 ± 0.80 2.72 ± 0.69 2.59 ± 0.67 2.9 ± 0.54
FT4 (ng/dl) 1.4 ± 0.45 1.35 ± 0.36 1.46 ± 0.32 1.23 ± 0.43
Thyroid volume (ml) 12.87 ± 4.90b* 14.91 ± 5.68 13.01 ± 4.51b* 16.96 ± 6.8
Thyroid nodule n (%)
•Palpable n (%)
•Non-palpable n (%)
8/62 (12.9%)b*
3/8 (37.5%)
5/8 (62.5%)
10/40 (25%)
3/10 (30%)
7/10 (70%)
3/22 (13.6%)
1/3 (33.3%)
2/3 (66.6%)
7/18 (38.8%)
2/7 (28.6%)
5/7 (71.4%)
Data are expressed as mean ± standard deviation or percentages
a: versus total PCOS, b: versus IR-PCOS, c: versus NIR-PCOS, *P < 0.05, **P < 0.01
Table 2: Thyroid function and volume in PCOS women and controls.